No Data
No Data
MaxCyte(MXCT.US) Officer Sells US$134.37K in Common Stock
MaxCyte to Unveil Q2 2024 Financial Results
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024
MaxCyte Announces Broker Name Change Post-Merger
MaxCyte Director Executes Options and Sells Shares
MaxCyte Issues New Shares, Updates Voting Rights
No Data